Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Bladder Cancer

  Free Subscription


01.07.2019

1 Aktuelle Urol
1 APMIS
1 BMC Urol
2 BMJ Case Rep
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Treat Rev
1 Cell Adh Migr
1 Cell Death Differ
1 Cesk Patol
1 Clin Genitourin Cancer
1 Epigenetics
1 Eur Urol Focus
1 Eur Urol Oncol
2 Future Oncol
1 Hinyokika Kiyo
1 Int Braz J Urol
1 Int J Urol
1 Int Urol Nephrol
1 Invest New Drugs
1 J Agric Food Chem
1 J Exp Clin Cancer Res
1 Medicina (Kaunas)
2 Mol Cancer
1 Onco Targets Ther
1 Oncol Rep
1 PLoS One
1 Prog Urol
1 Rev Urol
1 Urol Oncol
1 Vet Microbiol
1 Virchows Arch


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Aktuelle Urol

  1. RETZ M, von Amsberg G, Horn T, Gschwend JE, et al
    [50 years of systemic therapy of urinary bladder cancer].
    Aktuelle Urol. 2019 Jun 26. doi: 10.1055/a-0945-8340.
    PubMed     Text format     Abstract available


    APMIS

  2. BLANCA A, Sanchez-Gonzalez A, Requena MJ, Carrasco-Valiente J, et al
    Expression of miR-100 and miR-138 as prognostic biomarkers in Non- Muscle Invasive Bladder Cancer.
    APMIS. 2019 Jun 24. doi: 10.1111/apm.12973.
    PubMed     Text format     Abstract available


    BMC Urol

  3. HAYASHIDA Y, Miyata Y, Matsuo T, Ohba K, et al
    A pilot study to assess the safety and usefulness of combined transurethral endoscopic mucosal resection and en-bloc resection for non-muscle invasive bladder cancer.
    BMC Urol. 2019;19:56.
    PubMed     Text format     Abstract available


    BMJ Case Rep

  4. MASSIE J, Howling S
    Schistosoma haematobium causing pulmonary schistosomiasis in a returning traveller.
    BMJ Case Rep. 2019;12.
    PubMed     Text format     Abstract available

  5. JAYAWARDHANA T, Alsayed H, Goel A, Madaan S, et al
    Non-muscle-invasive clear cell carcinoma of the urinary bladder: Is cystectomy necessary?
    BMJ Case Rep. 2019;12.
    PubMed     Text format     Abstract available


    Cancer Epidemiol Biomarkers Prev

  6. SCHULPEN M, van den Brandt PA
    Adherence to the Mediterranean diet and risks of prostate and bladder cancer in the Netherlands Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2019 Jun 24. pii: 1055-9965.EPI-19-0224.
    PubMed     Text format     Abstract available


    Cancer Treat Rev

  7. GHATE K, Amir E, Kuksis M, Hernandez-Barajas D, et al
    PD-L1 expression and clinical outcomes in patients with advanced urothelial carcinoma treated with checkpoint inhibitors: A meta-analysis.
    Cancer Treat Rev. 2019;76:51-56.
    PubMed     Text format     Abstract available


    Cell Adh Migr

  8. JIN H, Xue L, Mo L, Zhang D, et al
    Downregulation of miR-200c stabilizes XIAP mRNA and contributes to invasion and lung metastasis of bladder cancer.
    Cell Adh Migr. 2019;13:236-248.
    PubMed     Text format     Abstract available


    Cell Death Differ

  9. HUA X, Huang M, Deng X, Xu J, et al
    The inhibitory effect of compound ChlA-F on human bladder cancer cell invasion can be attributed to its blockage of SOX2 protein.
    Cell Death Differ. 2019 Jun 26. pii: 10.1038/s41418-019-0377.
    PubMed     Text format     Abstract available


    Cesk Patol

  10. KRISTYNA P, Tomas P, Ondrej H
    Current status of urine cytology: What new does The Paris System for Reporting Urine Cytology bring?
    Cesk Patol. 2019;55:34-41.
    PubMed     Text format     Abstract available


    Clin Genitourin Cancer

  11. SUNG JM, Martin JW, Jefferson FA, Sidhom DA, et al
    Racial and Socioeconomic Disparities in Bladder Cancer Survival: Analysis of the California Cancer Registry.
    Clin Genitourin Cancer. 2019 May 31. pii: S1558-7673(19)30146.
    PubMed     Text format     Abstract available


    Epigenetics

  12. JORDAHL KM, Phipps AI, Randolph TW, Tindle HA, et al
    Differential DNA methylation in blood as a mediator of the association between cigarette smoking and bladder cancer risk among postmenopausal women.
    Epigenetics. 2019 Jun 23:1-9. doi: 10.1080/15592294.2019.1631112.
    PubMed     Text format     Abstract available


    Eur Urol Focus

  13. KRIMPHOVE MJ, Szymaniak J, Marchese M, Tully KH, et al
    Sex-specific Differences in the Quality of Treatment of Muscle-invasive Bladder Cancer Do Not Explain the Overall Survival Discrepancy.
    Eur Urol Focus. 2019 Jun 18. pii: S2405-4569(19)30156.
    PubMed     Text format     Abstract available


    Eur Urol Oncol

  14. ROUPRET M, Malmstrom PU, Black P
    Recurrent Ta Low-grade Non-muscle-invasive Bladder Cancer: What Are the Options?
    Eur Urol Oncol. 2019 Jun 22. pii: S2588-9311(19)30078.
    PubMed     Text format     Abstract available


    Future Oncol

  15. ABDEL-RAHMAN O
    Bladder cancer mortality after a diagnosis of nonmuscle-invasive bladder carcinoma.
    Future Oncol. 2019 Jun 25. doi: 10.2217/fon-2018-0861.
    PubMed     Text format     Abstract available

  16. HUANG C, Zhou W, Song P, Yuan N, et al
    Comparison of different prognostic models for predicting cancer-specific survival in bladder transitional cell carcinoma.
    Future Oncol. 2019;15:851-864.
    PubMed     Text format     Abstract available


    Hinyokika Kiyo

  17. KATO D, Kawase M, Ishida T, Kato S, et al
    [Investigation of Clinical Outcome and Prognosis of 2nd TUR-Bt for T1 High Grade Bladder Cancer].
    Hinyokika Kiyo. 2019;65:105-109.
    PubMed     Text format     Abstract available


    Int Braz J Urol

  18. VURUSKAN BA, Ozsen M, Coskun B, Yalcinkaya U, et al
    Evaluation of incidence and histolopathological findings of soft tissue sarcomas in genitourinary tract: Uludag university experience.
    Int Braz J Urol. 2019;45:68-73.
    PubMed     Text format     Abstract available


    Int J Urol

  19. YASUI M, Kawahara T, Takamoto D, Izumi K, et al
    Distribution of androgen receptor expression in the urinary bladder.
    Int J Urol. 2019;26:305-306.
    PubMed     Text format    


    Int Urol Nephrol

  20. XU R, Li H, Wu S, Qu J, et al
    MicroRNA-1246 regulates the radio-sensitizing effect of curcumin in bladder cancer cells via activating P53.
    Int Urol Nephrol. 2019 Jun 24. pii: 10.1007/s11255-019-02210.
    PubMed     Text format     Abstract available


    Invest New Drugs

  21. ZAHOOR H, Mir MC, Barata PC, Stephenson AJ, et al
    Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer.
    Invest New Drugs. 2019 Jun 24. pii: 10.1007/s10637-018-00716.
    PubMed     Text format     Abstract available


    J Agric Food Chem

  22. XIA Y, Kang TW, Jung DY, Zhang C, et al
    Sulforaphane inhibits non-muscle invasive bladder cancer cells proliferation through suppression of HIF-1alpha-mediated glycolysis in hypoxia.
    J Agric Food Chem. 2019 Jun 26. doi: 10.1021/acs.jafc.9b03027.
    PubMed     Text format     Abstract available


    J Exp Clin Cancer Res

  23. HUANG CP, Chen J, Chen CC, Liu G, et al
    ASC-J9(R) increases the bladder cancer chemotherapy efficacy via altering the androgen receptor (AR) and NF-kappaB survival signals.
    J Exp Clin Cancer Res. 2019;38:275.
    PubMed     Text format     Abstract available


    Medicina (Kaunas)

  24. STOJNEV S, Krstic M, Cukuranovic Kokoris J, Conic I, et al
    Prognostic Impact of Canonical TGF-beta Signaling in Urothelial Bladder Cancer.
    Medicina (Kaunas). 2019;55.
    PubMed     Text format     Abstract available


    Mol Cancer

  25. LU Q, Liu T, Feng H, Yang R, et al
    Circular RNA circSLC8A1 acts as a sponge of miR-130b/miR-494 in suppressing bladder cancer progression via regulating PTEN.
    Mol Cancer. 2019;18:111.
    PubMed     Text format     Abstract available

  26. HAN J, Wang JZ, Yang X, Yu H, et al
    METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.
    Mol Cancer. 2019;18:110.
    PubMed     Text format     Abstract available


    Onco Targets Ther

  27. SHI X, Chen S, Zhang Y, Xie W, et al
    Norcantharidin inhibits the DDR of bladder cancer stem-like cells through cdc6 degradation.
    Onco Targets Ther. 2019;12:4403-4413.
    PubMed     Text format     Abstract available


    Oncol Rep

  28. XUE Y, Tong L, LiuAnwei Liu F, Liu A, et al
    Tumorinfiltrating M2 macrophages driven by specific genomic alterations are associated with prognosis in bladder cancer.
    Oncol Rep. 2019 Jun 12. doi: 10.3892/or.2019.7196.
    PubMed     Text format     Abstract available


    PLoS One

  29. LIU W, Woolbright BL, Pirani K, Didde R, et al
    Tumor M2-PK: A novel urine marker of bladder cancer.
    PLoS One. 2019;14:e0218737.
    PubMed     Text format     Abstract available


    Prog Urol

  30. TOSTIVINT V, Roumiguie M, Cabarrou B, Verhoest G, et al
    [Orthotopic neobladder reconstruction for bladder cancer: robotic-assisted versus open-radical cystectomy for perioperative outcomes, functional results and quality of life].
    Prog Urol. 2019 Jun 22. pii: S1166-7087(19)30115.
    PubMed     Text format     Abstract available


    Rev Urol

  31. SCHULSTER M
    Bladder Cancer Academy 2019 Selected Summaries.
    Rev Urol. 2019;21:23-28.
    PubMed     Text format    


    Urol Oncol

  32. MITCHELL KA, Williams H
    Emerging genomic biomarkers for improving kidney, prostate, and bladder cancer health disparities outcomes.
    Urol Oncol. 2019 Jun 22. pii: S1078-1439(19)30157.
    PubMed     Text format     Abstract available


    Vet Microbiol

  33. ROPERTO S, Russo V, De Falco F, Urraro C, et al
    Bovine papillomavirus E5 oncoprotein expression and its association with an interactor network in aggresome-autophagy pathway.
    Vet Microbiol. 2019;233:39-46.
    PubMed     Text format     Abstract available


    Virchows Arch

  34. REBOLA J, Aguiar P, Blanca A, Montironi R, et al
    Predicting outcomes in non-muscle invasive (Ta/T1) bladder cancer: the role of molecular grade based on luminal/basal phenotype.
    Virchows Arch. 2019 Jun 25. pii: 10.1007/s00428-019-02593.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: